COVID-19 has ‘strong affinity’ for damaging kidney cells

France Nouvelles Nouvelles

COVID-19 has ‘strong affinity’ for damaging kidney cells
France Dernières Nouvelles,France Actualités
  • 📰 TheStarPhoenix
  • ⏱ Reading Time:
  • 30 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 15%
  • Publisher: 63%

A new study published in FrontCellDevBio explains the connection between rising COVID-19 case counts in early 2020 and the growing number of kidney injuries - via healthing_ca healthing COVID19 news

The device's 91 per cent accuracy would be an upgrade from the rapid antigen tests most Canadians have been relying on.“It was shocking to hear doctors describe how patients who were healthy suddenly developed kidney injury and needed to go on dialysis after contracting SARS-CoV-2,”, an assistant professor of biomedical engineering and medicine at Duke University.

To test their podocyte model with a live version of SARS-CoV-2, Musah and Kalejaiye joined forces with Maria Blasi, an assistant professor of medicine at Duke, who was exploring how viruses such as HIV are capable of infecting and damaging another type of kidney cell known as renal tubular epithelial cells.

“I think it’s remarkable that we went from being home and hearing the initial reports from physicians to forming this collaboration virtually and having these results on such a short timeline,” Musah said. “We had the right people and the right tools at the right time.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

TheStarPhoenix /  🏆 253. in US

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

FDA approves COVID drug for children, China deals with uphill COVID battle, and more COVID newsFDA approves COVID drug for children, China deals with uphill COVID battle, and more COVID newsThe US Food and Drug Administration announced Monday that it has expanded approval of the COVID-19 drug remdesivir to treat patients as young as 28 days old. Here's that and more COVID news.
Lire la suite »

'Milestone' as Covid-19 cases in Irish hospitals fall below 500'Milestone' as Covid-19 cases in Irish hospitals fall below 500Minister of Health Stephen Donnelly says all of the data is 'trending in the right direction'.
Lire la suite »

21 defendants charged in alleged $149 million COVID-19 fraud schemes21 defendants charged in alleged $149 million COVID-19 fraud schemesPhysicians, marketers and medical businesses across nine U.S. federal districts are among those facing charges.
Lire la suite »

What experts told me to do after my positive COVID-19 at-home testWhat experts told me to do after my positive COVID-19 at-home testIt gets complicated to figure out how to report results and when you’re no longer contagious. COVID19 COVIDTesting Pandemic HomeTesting
Lire la suite »

UK patient had COVID-19 for 505 days straight, study showsUK patient had COVID-19 for 505 days straight, study showsScientists say a U.K. patient with a severely weakened immune system had COVID-19 for almost a year and a half.
Lire la suite »

Beijing locks down some areas as COVID-19 cases mountBeijing locks down some areas as COVID-19 cases mountChina's capital, Beijing, began mass testing of more than 3 million people on Monday and restricted residents in one part of the city to their compounds, sparking worries of a wider Shanghai-style lockdown. While only 70 cases have been found so far in the city of more than 21 million since a new outbreak surfaced Friday, authorities have rolled out strict measures under China's “zero-COVID” approach to try to prevent a further spread of the virus. Shanghai, which has been locked down for more than two weeks, reported more than 19,000 new infections and 51 deaths in the latest 24-hour period, pushing its announced death toll from the ongoing outbreak to 138.
Lire la suite »



Render Time: 2025-04-05 14:26:08